Back to top

Grifols Half-Year 2026 Results: Profit Jumps as Refinancing Bolsters Balance Sheet

An announcement from Grifols SA ( ($GRFS) ) is now available. Grifols is a global producer of plasma-derived medicines, with leading franchises in ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Grifols, S.A. (GRFS)